PROMOTION
LIPOSONIX ADVANCED BODY SHAPING
Interviews with Liposonix experts:
Rita Rakus, Dermatologist, UK
Jean-Michel Mazer, Dermatologist, France
Afschin Fatemi, Dermatologic Surgeon, Germany
the Liposonix Model 2, Solta Medical (Hayward, Calif., USA) is making a huge impact in the global body shaping arena. A truly non-invasive device, the Liposonix system effectively harnesses high-intensity focused ultrasound (HIFU) energy to destroy subcutaneous fat at a pre-determined depth, bypassing the epidermis entirely, enhancing recovery and reducing potential downtime. The technology is widely available in Europe and Canada, and in September 2011 received FDA clearance for use in the US. ‘This acquisition is a testament to Solta Medical’s credibility,’ said London-based dermatologist Rita Rakus, medical director of CMA Ltd., the largest non-surgical aesthetic practice in the UK. ‘Solta [Medical] exhibits a composite of foundational aesthetic procedures and the addition of the Liposonix system perfectly complements the well-documented and successful laser and radiofrequency modalities in their product portfolio. They are an acknowledged industry leader with a solid reputation.’ Dermatologist Jean-Michel Mazer,
W
founder and medical director of Centre Laser International de la Peau Paris (Paris, France) agrees: ‘Solta [Medical] is the leader in
ITH THE RECENT acquisition of the Liposonix® system and the release of its newest system,
(A) Before treatment with Liposonix, and (B) 2-months post-treatment showing a 1.8 cm reduction. (Images courtesy of Solta Medical Aesthetic Center.)
(A) Before treatment with Liposonix, and (B) 2-months post-treatment showing a 5.05 cm reduction. (Images courtesy of Solta Medical Aesthetic Center.)
effective non-invasive aesthetic procedures on the face and body. Increasing their body contouring presence with the Liposonix system is a logical move because it is a clear complement to the Thermage CPT™ system (also from Solta Medical), the utility of which was further advanced by the success of the 16 cm body tip.’
System features The Liposonix system uses high levels of ultrasound energy (between 1000 W/cm2
and 3000 W/cm2 ), focused at 1.3 cm below the dermis
to create a therapeutic level of thermal damage to adipose tissue. Skin and other underlying tissue is spared. Over time, the body’s natural waste removal system processes clear free-floating fat and cellular debris. An exclusive feature of the
Model 2 device is the Custom Contouring™ capability, which ‘allows for more selective and effective treatment of even smaller areas of fat, including the area around the umbilicus, which is unique to the Liposonix Model 2 system,’ said Dr Rakus. According to Afschin Fatemi,
Thomas Proebstle, Dermatologist, Germany
78 ❚ March 2012 |
prime-journal.com
medical director of S-thetic Clinic (Dusseldorf, Germany), no other device with this kind of research and supportive histological evidence behind it is capable of
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112